Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 2
---
us, constitute a prospectus that
meets the requirements of Section 10(a) of the Securities Act.

: The material that follows
Item 2, up to but not including Part II of this Registration Statement, of which the reoffer prospectus is a part, constitutes a “reoffer
prospectus,” prepared in accordance with the requirements of Part I of Form S-3 under the Securities Act. Pursuant to Instruction
C of Form S-8, the reoffer prospectus may be used for reoffers or resales of shares of common stock which are deemed to be “control
securities” or “restricted securities” under the Securities Act that have been acquired by the selling stockholders
named in the reoffer prospectus.

Item 1. Plan Information.

INmune Bio Inc. will provide each participant
(the “Recipient”) with documents that contain information related to the 2021 Plan, and other information including, but not
limited to, the disclosure required by Item 1 of Form S-8, which information is not filed as a part of this Registration Statement on
Form S-8. The foregoing information and the documents incorporated by reference in response to Item 3 of Part II of this Registration
Statement taken together constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act. A Section 10(a) prospectus
will be given to each Recipient who receives shares of common stock covered by this Registration Statement, in accordance with Rule 428(b)(1)
under the Securities Act.

Item 2. Registrant Information and Employee Plan Annual Information.

We will provide to each Recipient a written statement
advising it of the availability of documents incorporated by reference in Item 3 of Part II of this Registration Statement and of documents
required to be delivered pursuant to Rule 428(b) under the Securities Act without charge and upon written or oral notice by contacting:

<div align='center'>INmune Bio Inc.

225 NE Mizner Blvd., Suite
640

Boca Raton, FL 33432

Attention: Corporate Secretary

Telephone: (561) 710-0512</div>

Information required by Part I to be contained in Section 10(a) prospectus is omitted from the Registration Statement in accordance with Rule 428 under the Securities Act.

REOFFER PROSPECTUS

<div align='center'>INmune Bio Inc.

3,065,332 Shares of Common Stock</div>

This reoffer